Bryan Johnson’s Psychedelic Quest for Immortality: A Livestreamed Shrooms Experiment
In a bold and unconventional move, entrepreneur Bryan Johnson, renowned for his ventures in technology and health, recently embarked on a public experiment to explore the potential of psychedelics in his pursuit of extending human life. On December 2, 2025, Johnson livestreamed his experience of consuming 5.24 grams of psilocybin mushrooms, aiming to assess their impact on longevity and cognitive enhancement.
A Public Display of Psychedelic Exploration
The livestream, which attracted over a million viewers on the platform X, featured Johnson’s real-time reactions and physiological responses as he ingested the substantial dose of psilocybin. Utilizing technology from his neurotechnology company, Kernel, Johnson wore a sophisticated helmet designed to monitor brain activity, providing viewers with a unique insight into the effects of psychedelics on the human brain.
The event was not merely a personal experiment but also served as a platform to promote Johnson’s other ventures, including Blueprint, a company offering supplements and health products. The production included graphics reminiscent of early computer interfaces, adding a nostalgic touch to the modern scientific exploration.
Support from Silicon Valley Luminaries
The livestream garnered attention from several high-profile figures in the tech industry. Marc Benioff, CEO of Salesforce, drew parallels between Johnson’s journey and the biblical story of Jacob, suggesting a profound quest for transformation and enlightenment. This support underscores a growing interest within Silicon Valley in exploring unconventional methods to enhance human potential and longevity.
Johnson’s Ongoing Pursuit of Longevity
Bryan Johnson’s exploration into psychedelics is part of a broader, highly publicized campaign to extend human life. His methods have included receiving plasma transfusions from his son, consuming over 100 pills daily, and undergoing various experimental treatments. These efforts are meticulously documented on social media, reflecting a transparent approach to biohacking and longevity research.
In March 2025, Johnson announced plans to initiate foodome sequencing, aiming to analyze the composition of foods that constitute a significant portion of the American diet. This initiative seeks to identify and mitigate the presence of toxins in everyday foods, further contributing to his mission of promoting health and longevity.
The Intersection of Technology and Human Enhancement
Johnson’s endeavors highlight the intersection of technology, health, and human enhancement. By leveraging advancements in neurotechnology and biotechnology, he aims to push the boundaries of human potential. His company, Kernel, focuses on developing brain-monitoring devices that could revolutionize our understanding of the human mind and its capabilities.
Public Perception and Ethical Considerations
While Johnson’s methods have attracted admiration from some quarters, they have also sparked debate and skepticism. Critics question the ethical implications of such experiments and the potential risks involved. The public nature of his experiments raises questions about the influence of tech entrepreneurs in shaping health and wellness trends.
Conclusion
Bryan Johnson’s livestreamed psilocybin experiment represents a significant moment in the ongoing discourse on human enhancement and longevity. By combining personal experimentation with technological innovation, Johnson continues to challenge conventional boundaries, prompting both intrigue and critical discussion about the future of human health and the role of technology in extending life.
